Two “forever chemicals” would be designated hazardous substances under a rule the EPA proposed Friday that moves industries and federal facilities a step closer to strict liability to pay for their current or past releases of the compounds.

President Joe Biden‘s move to forgive billions in student loans, as part of his administration’s response to the Covid-19 pandemic, is drawing the same sort of legal scrutiny he’s received for policy changes he made without specific permission from Congress.

California’s $1.2 million penalty against Sephora for breaching the state’s landmark consumer data privacy law signals ramped-up regulatory scrutiny of the sale of personal information.

Recent threats against the IRS are a reminder of the importance of civility—especially in the tax profession.

Posting a video to social media that falsely implies others have monkeypox could be grounds for a libel lawsuit, defamation attorneys say.

A House report detailing coordinated attempts by Trump White House officials to influence the FDA’s pandemic response underscores the need for more transparency at an agency that’s facing historically low public trust, health policy analysts say.

A federal appeals court in New Orleans can extend anti-discrimination law’s reach into the workplace in a case involving a religious challenge to a health-care company’s Covid-19 vaccine mandate.